EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Retrospective, observational study of different medication regimens and outcome in children with cough variant asthma

Nannan Lou iD, Xiang Ma iD, Qingxin Luo, Xiaoling Wei, Yun Zhang, Jing Guo, Jing Wang, Zhongtao Gai

Immunity, Inflammation and Disease · 2024

DOI: 10.1002/iid3.1357 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Immunity, Inflammation and Disease, 2024. Verfasst von Nannan Lou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Diseases, Children's Hospital Affiliated to Shandong University (Jinan Children's Hospital), Jinan, Shandong, China. Hauptthemen laut MEDLINE: Asthma, Cough, Drug Therapy, Combination, Adrenal Cortex Hormones. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shandong Provincial Natural Science Program, Jinan Key Laboratory of Respiratory Disease for Children, Clinical Science and Technology Innovation Plan in Jinan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This retrospective longitudinal cohort study aimed to explore the best therapeutic regimen and treatment duration of cough variant asthma (CVA) in children.

Methods

A total of 314 children with CVA were divided into receive inhaled corticosteroids (ICS) combined with long‐acting beta2‐agonist (LABA) group, ICS combined with leukotriene receptor antagonists (LTRA) group, ICS monotherapy group and LTRA monotherapy group. All clinical data were statistically analyzed. Logistic regression model was used to compare the advantages and disadvantages of different treatment schemes at each follow‐up time point and the best treatment scheme. The Cox proportional hazard regression model based on inverse probability weighting was used to compare the effects of different medication regimens on adverse outcomes with asthma recurrence or progression as the end point.

Results

(1) After comprehensive analysis, ICS + LABA group was the preferred control regimen for CVA within 8 weeks. After 8 weeks of diagnosis, the efficacy of ICS group or LTRA group was comparable to that of ICS + LABA group and ICS + LTRA group. (2) The ICS + LABA group showed a significant improvement in cough at an early stage, particularly at 4 weeks; the symptoms of ICS + LTRA and ICS groups were significantly improved at 36 weeks. The LTRA group alone showed significant improvement at 20 weeks.

Conclusion

ICS + LABA, ICS + LTRA, ICS alone and LTRA alone can effectively treat CVA. ICS + LABA could improve the symptoms most quickly within 8 weeks after CVA diagnosis, followed by ICS + LATR group. After 8 weeks, it can be reduced to ICS alone to control CVA for at least 36 weeks based on the remission of symptoms in children.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaCoughDrug Therapy, CombinationAdrenal Cortex HormonesLeukotriene AntagonistsAnti-Asthmatic AgentsHumansRetrospective StudiesFemaleMaleChildTreatment OutcomeAdministration, InhalationChild, PreschoolLongitudinal StudiesAdrenergic beta-2 Receptor AgonistsAdolescentCough-Variant Asthma

Stichwörter der Autor:innen

childrencough variant asthmatreatment strategy

Substanzen

Adrenal Cortex HormonesLeukotriene AntagonistsAnti-Asthmatic AgentsAdrenergic beta-2 Receptor Agonists

Autor:innen und Institutionen

  • Department of Respiratory Diseases, Children's Hospital Affiliated to Shandong University (Jinan Children's Hospital), Jinan, Shandong, China.
  • Jinan Key Laboratory of Pediatric Respiratory diseases, Jinan Children's Hospital, Jinan, Shandong, China.
  • Department of Biostatistics, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, People's Republic of China.
  • Institute for Medical Dataology, Cheeloo College of Medicine, Shandong University, Jinan, People's Republic of China.

ORCID-Profile: Nannan Lou, Xiang Ma

Förderung

  • Shandong Provincial Natural Science Program
  • Jinan Key Laboratory of Respiratory Disease for Children
  • Clinical Science and Technology Innovation Plan in Jinan

Zitieren

APA

Lou, N., Ma, X., Luo, Q., Wei, X., Zhang, Y., Guo, J., Wang, J., & Gai, Z. (2024). Retrospective, observational study of different medication regimens and outcome in children with cough variant asthma. Immunity, Inflammation and Disease. https://doi.org/10.1002/iid3.1357

Vancouver

Lou N, Ma X, Luo Q, Wei X, Zhang Y, Guo J, et al. Retrospective, observational study of different medication regimens and outcome in children with cough variant asthma. Immunity, Inflammation and Disease. 2024. doi:10.1002/iid3.1357

BibTeX
@article{Lou2024,
  author = {Lou, Nannan and Ma, Xiang and Luo, Qingxin and Wei, Xiaoling and Zhang, Yun and Guo, Jing and Wang, Jing and Gai, Zhongtao},
  title = {Retrospective, observational study of different medication regimens and outcome in children with cough variant asthma},
  journal = {Immunity, Inflammation and Disease},
  year = {2024},
  doi = {10.1002/iid3.1357}
}
Kostenlos starten →